Lessons From the H1N1 Flu Epidemic

Home Forums Medical issues in Dentistry Lessons From the H1N1 Flu Epidemic

Welcome Dear Guest

To create a new topic please register on the forums. For help contact : discussdentistry@hotmail.com

Currently, there are 0 users and 1 guest visiting this topic.
Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • #10226
    drsushant
    Offline
    Registered On: 14/05/2011
    Topics: 253
    Replies: 277
    Has thanked: 0 times
    Been thanked: 0 times

    The H1N1 flu epidemic has lessons to offer healthcare providers, as the limited supply of vaccine initially left pregnant wo­men, small children with medical conditions, and oth­er high-risk groups waiting in long lines. The problems encountered in reaching certain populations ap­ply to the provision of dental care as well as other disciplines. An editorial in the journal Anes­the­sia Prog­ress discusses the ineq­uities of the healthcare de­livery system that be­came apparent in the distribution of the H1N1 flu vaccine. Early distribution did not adequately address certain high-risk groups, such as those who are homebound or have phys­­ical or mental impairment making them unable to wait in long lines. Meet­ing the dental needs of these high-risk groups also poses a challenge for dentists. Spe­cial needs patients are too often overlooked by dentists be­cause of a lack of experience managing this type of patient. The au­thor asserts that, “the addition of a highly skilled mobile am­bulatory general anesthesia practitioner can transform a dentist’s office into a fully moni­tored mini-operating room.” This would allow dentists to provide safe, high-quality care to people who cannot otherwise co­operate with treatment. The advanced training of a dental anesthesiologist al­ready requires extensive ex­peri­ence in providing ambu­latory general anesthesia to dental pa­tients with special needs. New ultra-short-acting drugs offer a ra­pid recovery, allowing office efficiency for dentists and cost savings for patients. Finding different avenues to meet the needs of special populations is a lesson for government and medical communities. The solutions found in the dental profession may provide a model. The author also notes positive changes in the healthcare community and be­yond be­cause of the H1N1 flu epidemic. Much as the impact of the HIV/AIDS vi­rus spawned the wearing of gloves and other protective equipment by dental professionals, this epidemic is also bringing about transformations. These include a better awareness of hygiene and improved measures, such as hand washing, that will de­crease the spread of illness.

    #15006
    drmithila
    Offline
    Registered On: 14/05/2011
    Topics: 242
    Replies: 579
    Has thanked: 0 times
    Been thanked: 0 times

    The 2009 flu pandemic or swine flu was an influenza pandemic, and the second of the two pandemics involving H1N1 influenza virus (the first of them was the 1918 flu pandemic), albeit in a new version. First described in April 2009, the virus appeared to be a new strain of H1N1 which resulted when a previous triple reassortment of bird, swine and human flu viruses further combined with a Eurasian pig flu virus, leading to the term “swine flu” to be used for this pandemic. Unlike most strains of influenza, H1N1 does not disproportionately infect adults older than 60 years; this was an unusual and characteristic feature of the H1N1 pandemic. Even in the case of previously very healthy persons, a small percentage will develop pneumonia or acute respiratory distress syndrome. This manifests itself as increased breathing difficulty and typically occurs 3–6 days after initial onset of flu symptoms. The pneumonia caused by flu can be either direct viral pneumonia or a secondary bacterial pneumonia. In fact, a November 2009 New England Journal of Medicine article recommends that flu patients whose chest X-ray indicates pneumonia receive both antivirals and antibiotics. In particular, it is a warning sign if a child (and presumably an adult) seems to be getting better and then relapses with high fever, as this relapse may be bacterial pneumonia.
    Initially coined an “outbreak”, the stint began in the state of Veracruz, Mexico, with evidence that there had been an ongoing epidemic for months before it was officially recognized as such. The Mexican government closed most of Mexico City’s public and private facilities in an attempt to contain the spread of the virus; however, it continued to spread globally, and clinics in some areas were overwhelmed by infected people. In June, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) stopped counting cases and declared the outbreak a pandemic.
    Despite being informally called “swine flu”, the H1N1 flu virus cannot be spread by eating pork or pork products; similar to other influenza viruses, it is typically contracted by person to person transmission through respiratory droplets. Symptoms usually last 4–6 days. Antivirals (oseltamivir or zanamivir) were recommended for those with more severe symptoms or those in an at-risk group.
    The pandemic began to taper off in November 2009, and by May 2010, the number of cases was in steep decline. On 10 August 2010, the Director-General of the World Health Organization, Margaret Chan, announced the end of the H1N1 pandemic, and announced that the H1N1 influenza event has moved into the post-pandemic period. According to the latest WHO statistics (July 2010), the virus has killed more than 18,000 people since it appeared in April 2009, however they state that the total mortality (including deaths unconfirmed or unreported) from the H1N1 strain is “unquestionably higher”. Critics claimed the WHO had exaggerated the danger, spreading “fear and confusion” rather than “immediate information”. The WHO began an investigation to determine whether it had “frightened people unnecessarily”. A flu followup study done in September 2010, found that “the risk of most serious complications was not elevated in adults or children.” In an August 5, 2011 PLoS ONE article, researchers estimated that the 2009 H1N1 global infection rate was 11% to 21%, lower than what was previously expected. Serbia’s B92 investigative reporting concluded that vaccine was not properly tested.

Viewing 2 posts - 1 through 2 (of 2 total)
  • You must be logged in to reply to this topic.